Israeli startup Remilk Ltd., a developer of lab-grown milk, secured a $20 million investment from UAE-based Tau Capital, an investment firm backed by Sheikh Tahnoon bin Zayed Al Nahyan. This funding represents a rare cross-border investment from the Persian Gulf into Israel since the start of the Gaza war, signaling continued economic engagement despite regional geopolitical tensions.
Remilk Ltd., an Israeli startup focused on lab-grown milk, has successfully secured $20 million in funding from Tau Capital, a UAE-based investment firm backed by Sheikh Tahnoon bin Zayed Al Nahyan. This private venture capital round, disclosed by CEO Aviv Wolff, highlights significant capital inflow into the alternative protein sector and represents a notable financial commitment to an Israeli technology firm. This investment was secured last year, with details now publicly shared. This transaction is particularly noteworthy as it marks a rare cross-border investment from the Persian Gulf into Israel since the onset of the Gaza war, signaling continued economic engagement despite regional geopolitical tensions. The moderately positive sentiment (0.55) and optimistic tone associated with this deal suggest a potential resilience in economic ties. While the direct market impact score is low (0.3), this is typical for private market transactions not involving publicly traded entities. The funding underscores growing interest in technology and innovation within the alternative food sector, specifically lab-grown dairy, aligning with broader healthcare and biotech themes. For Remilk, this capital infusion will likely accelerate product development and market entry, positioning it within a high-growth industry. This strategic investment could also pave the way for future cross-border collaborations in the private markets, despite geopolitical headwinds.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
